GRIFOLS reported EUR686.84M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Alcon AG USD 1.69B 175M Mar/2026
Almirall EUR 429.87M 180.02M Dec/2025
Amadeus IT EUR 754.9M 225.7M Mar/2026
Amarin USD 23.17M 961K Dec/2025
argenx SE USD 1.18B 40.98M Mar/2026
AstraZeneca USD 12.61B 225M Mar/2026
Bayer EUR 6.94B 1.58B Dec/2025
Cie Automotive EUR 805.54M 79.61M Dec/2024
Demant DKK 8.82B 277M Dec/2025
Ence Energia y Celulosa EUR 181.3M 102.02M Sep/2025
Essilor EUR 8.3B 547M Dec/2025
Ferrovial EUR 4.27B 498M Dec/2024
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.18B 210M Mar/2026
Genmab DKK 977M 13M Dec/2025
GlaxoSmithKline GBP 5.75B 429M Mar/2026
GRIFOLS EUR 686.84M 56.95M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Inditex EUR 6.41B 304M Dec/2025
Lakefront Biotherapeutics EUR 1.68M 898.68M Mar/2026
Merck EUR 3.07B 104M Mar/2026
Novartis USD 10.07B 184M Mar/2026
Philips EUR 1.77B 522M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Smith & Nephew USD 2.09B 117M Dec/2025
UCB EUR 3.19B 621M Dec/2025
Viscofan EUR 112.29M 226K Mar/2026